| Nov 1 |
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
|
| Oct 29 |
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
|
| Oct 25 |
Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
|
| Oct 24 |
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
|
| Oct 22 |
(TNXP) - Analyzing Tonix Pharmaceuticals's Short Interest
|
| Oct 17 |
Tonix stock climbs 6% on first payment under $34M DOD contract
|
| Oct 17 |
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
|
| Oct 16 |
Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals
|
| Oct 16 |
Tonix Pharmaceuticals announces submission of NDA for non-opioid analgesic
|
| Oct 16 |
Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
|
